Funding This study was supported by the Medical Science Research Program of Hebei Province (20220709), the Government Funded Clinical Medicine Excellent Talent Training Project (ZF2022034), and the Hebei Natural Science Foundation (H2022316005)
10.1007/s00467-010-1627-6 Kumar T, Sharma GS, Singh LR: Homocystinuria: Therapeutic approach
4 hours | Primary site of action: vascular signaling pathways, NO system | Key receptors: VEGFR2, eNOS | Research focus: gastrointestinal, tendons, inflammation | Endogenous: no (synthetic, derived from gastric juice) | Gene modulation: limited documentation TB-500 Half-life: approx
Based on preliminary preclinical research, BPC-157
Healing Incisional Skin Wounds: A Closer Look Key Findings: BPC-157, when applied topically at a dose of 10 g/kg, accelerated the healing of incisional skin wounds in rats